Literature DB >> 33828299

Type III-A CRISPR immunity promotes mutagenesis of staphylococci.

Charlie Y Mo1, Jacob Mathai2, Jakob T Rostøl2, Andrew Varble2, Dalton V Banh2,3, Luciano A Marraffini4,5.   

Abstract

Horizontal gene transfer and mutation are the two major drivers of microbial evolution that enable bacteria to adapt to fluctuating environmental stressors1. Clustered, regularly interspaced, short palindromic repeats (CRISPR) systems use RNA-guided nucleases to direct sequence-specific destruction of the genomes of mobile genetic elements that mediate horizontal gene transfer, such as conjugative plasmids2 and bacteriophages3, thus limiting the extent to which bacteria can evolve by this mechanism. A subset of CRISPR systems also exhibit non-specific degradation of DNA4,5; however, whether and how this feature affects the host has not yet been examined. Here we show that the non-specific DNase activity of the staphylococcal type III-A CRISPR-Cas system increases mutations in the host and accelerates the generation of antibiotic resistance in Staphylococcus aureus and Staphylococcus epidermidis. These mutations require the induction of the SOS response to DNA damage and display a distinct pattern. Our results demonstrate that by differentially affecting both mechanisms that generate genetic diversity, type III-A CRISPR systems can modulate the evolution of the bacterial host.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33828299      PMCID: PMC8820005          DOI: 10.1038/s41586-021-03440-3

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  54 in total

1.  The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA.

Authors:  Josiane E Garneau; Marie-Ève Dupuis; Manuela Villion; Dennis A Romero; Rodolphe Barrangou; Patrick Boyaval; Christophe Fremaux; Philippe Horvath; Alfonso H Magadán; Sylvain Moineau
Journal:  Nature       Date:  2010-11-04       Impact factor: 49.962

2.  Identification of novel non-coding RNAs as potential antisense regulators in the archaeon Sulfolobus solfataricus.

Authors:  Thean-Hock Tang; Norbert Polacek; Marek Zywicki; Harald Huber; Kim Brugger; Roger Garrett; Jean Pierre Bachellerie; Alexander Hüttenhofer
Journal:  Mol Microbiol       Date:  2005-01       Impact factor: 3.501

3.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

4.  Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition.

Authors:  Migle Kazlauskiene; Gintautas Tamulaitis; Georgij Kostiuk; Česlovas Venclovas; Virginijus Siksnys
Journal:  Mol Cell       Date:  2016-04-21       Impact factor: 17.970

5.  RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex.

Authors:  Caryn R Hale; Peng Zhao; Sara Olson; Michael O Duff; Brenton R Graveley; Lance Wells; Rebecca M Terns; Michael P Terns
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

Review 6.  Horizontal gene transfer and the evolution of bacterial and archaeal population structure.

Authors:  Martin F Polz; Eric J Alm; William P Hanage
Journal:  Trends Genet       Date:  2013-01-15       Impact factor: 11.639

7.  Small CRISPR RNAs guide antiviral defense in prokaryotes.

Authors:  Stan J J Brouns; Matthijs M Jore; Magnus Lundgren; Edze R Westra; Rik J H Slijkhuis; Ambrosius P L Snijders; Mark J Dickman; Kira S Makarova; Eugene V Koonin; John van der Oost
Journal:  Science       Date:  2008-08-15       Impact factor: 47.728

8.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

Review 9.  Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants.

Authors:  Kira S Makarova; Yuri I Wolf; Jaime Iranzo; Sergey A Shmakov; Omer S Alkhnbashi; Stan J J Brouns; Emmanuelle Charpentier; David Cheng; Daniel H Haft; Philippe Horvath; Sylvain Moineau; Francisco J M Mojica; David Scott; Shiraz A Shah; Virginijus Siksnys; Michael P Terns; Česlovas Venclovas; Malcolm F White; Alexander F Yakunin; Winston Yan; Feng Zhang; Roger A Garrett; Rolf Backofen; John van der Oost; Rodolphe Barrangou; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2019-12-19       Impact factor: 60.633

10.  CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity.

Authors:  Janice S Chen; Enbo Ma; Lucas B Harrington; Maria Da Costa; Xinran Tian; Joel M Palefsky; Jennifer A Doudna
Journal:  Science       Date:  2018-02-15       Impact factor: 47.728

View more
  11 in total

Review 1.  Alternative functions of CRISPR-Cas systems in the evolutionary arms race.

Authors:  Prarthana Mohanraju; Chinmoy Saha; Peter van Baarlen; Rogier Louwen; Raymond H J Staals; John van der Oost
Journal:  Nat Rev Microbiol       Date:  2022-01-06       Impact factor: 60.633

2.  CRISPR-Cas is associated with fewer antibiotic resistance genes in bacterial pathogens.

Authors:  Elizabeth Pursey; Tatiana Dimitriu; Fernanda L Paganelli; Edze R Westra; Stineke van Houte
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-11-29       Impact factor: 6.237

Review 3.  RNA-targeting CRISPR-Cas systems.

Authors:  Sam P B van Beljouw; Jasper Sanders; Alicia Rodríguez-Molina; Stan J J Brouns
Journal:  Nat Rev Microbiol       Date:  2022-09-28       Impact factor: 78.297

4.  Viral recombination systems limit CRISPR-Cas targeting through the generation of escape mutations.

Authors:  Amer A Hossain; Jon McGinn; Alexander J Meeske; Joshua W Modell; Luciano A Marraffini
Journal:  Cell Host Microbe       Date:  2021-09-27       Impact factor: 31.316

5.  Type I CRISPR-Cas provides robust immunity but incomplete attenuation of phage-induced cellular stress.

Authors:  Lucia M Malone; Hannah G Hampton; Xochitl C Morgan; Peter C Fineran
Journal:  Nucleic Acids Res       Date:  2022-01-11       Impact factor: 16.971

Review 6.  Type III CRISPR-Cas Systems: Deciphering the Most Complex Prokaryotic Immune System.

Authors:  Matvey V Kolesnik; Iana Fedorova; Karyna A Karneyeva; Daria N Artamonova; Konstantin V Severinov
Journal:  Biochemistry (Mosc)       Date:  2021-10       Impact factor: 2.487

Review 7.  Digging into the lesser-known aspects of CRISPR biology.

Authors:  Noemí M Guzmán; Belén Esquerra-Ruvira; Francisco J M Mojica
Journal:  Int Microbiol       Date:  2021-09-06       Impact factor: 2.479

8.  Genomic Comparisons and Phenotypic Diversity of Dickeya zeae Strains Causing Bacterial Soft Rot of Banana in China.

Authors:  Jingxin Zhang; Mohammad Arif; Huifang Shen; Dayuan Sun; Xiaoming Pu; John Hu; Birun Lin; Qiyun Yang
Journal:  Front Plant Sci       Date:  2022-02-09       Impact factor: 5.753

9.  Structural basis of cyclic oligoadenylate binding to the transcription factor Csa3 outlines cross talk between type III and type I CRISPR systems.

Authors:  Pengjun Xia; Anirudha Dutta; Kushol Gupta; Mona Batish; Vijay Parashar
Journal:  J Biol Chem       Date:  2022-01-14       Impact factor: 5.157

10.  Structural and biochemical characterization of in vivo assembled Lactococcus lactis CRISPR-Csm complex.

Authors:  Sagar Sridhara; Jay Rai; Charlisa Whyms; Hemant Goswami; Huan He; Walter Woodside; Michael P Terns; Hong Li
Journal:  Commun Biol       Date:  2022-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.